NCT07487220

Brief Summary

This prospective randomized clinical study investigates the effects of Remote Ischemic Conditioning (RIC) on tissue perfusion and ischemia-reperfusion injury in patients undergoing free flap reconstruction in reconstructive microsurgery. RIC is a non-invasive conditioning technique using cyclic ischemia and reperfusion applied to an extremity, which may enhance microcirculation and induce tissue protection. The study aims to evaluate whether preoperative RIC improves postoperative flap perfusion, reduces ischemia-reperfusion- related tissue damage, and enhances clinical outcomes such as flap survival, wound healing, and need for revision surgery. Patients undergoing free flap procedures will be randomized to receive either preoperative RIC (immediate or delayed) or no conditioning. Additional analyses include continuous postoperative monitoring of microcirculation, histological and molecular assessment of tissue samples, and evaluation of circulating biomarkers associated with tissue protection.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

March 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 23, 2026

Completed
Last Updated

March 25, 2026

Status Verified

March 1, 2021

Enrollment Period

1.8 years

First QC Date

March 17, 2026

Last Update Submit

March 21, 2026

Conditions

Keywords

ischemiareperfusionfree flapWound Healing

Outcome Measures

Primary Outcomes (1)

  • Microcirculatory perfusion of free flap tissue measured by Laser-Doppler flowmetry and tissue spectrometry

    Continuous assessment of microcirculatory perfusion parameters of free flap tissue using combined Laser-Doppler flowmetry and tissue spectrometry (O2C system). Parameters include blood flow (BF), tissue oxygen saturation (StO₂), and relative hemoglobin concentration (rHb) measured in the transplanted tissue to evaluate the effect of remote ischemic conditioning on flap perfusion and ischemia-reperfusion injury.

    From intraoperative revascularization until postoperative day 5

Secondary Outcomes (2)

  • Incidence of flap tissue necrosis following free flap reconstruction

    Up to postoperative day 5

  • Histological markers of vascularization and ischemia-reperfusion injury in flap tissue

    From intraoperative sampling after revascularization until postoperative day 5-7

Study Arms (3)

No RIPC

NO INTERVENTION

No Remote Ischemic Conditioning (RIC) is administered. Participants receive standard perioperative care and undergo free flap reconstruction according to institutional protocols without any preconditioning intervention.

Early RIPC

EXPERIMENTAL

Remote Ischemic Conditioning (RIC) is performed 12-24 hours prior to surgery. The intervention consists of three cycles of ischemia and reperfusion applied to the upper arm using a pneumatic tourniquet. Each cycle includes 10 minutes of ischemia (inflation to approximately 250 mmHg) followed by 10 minutes of reperfusion (deflation). The total duration of the conditioning procedure is 60 minutes. Participants subsequently undergo free flap reconstruction according to standard institutional protocols.

Device: Remote ischemic preconditiong

Late RIPC

EXPERIMENTAL

Remote Ischemic Conditioning (RIC) is performed one hour prior to surgery. The intervention consists of three cycles of ischemia and reperfusion applied to the upper arm using a pneumatic tourniquet. Each cycle includes 10 minutes of ischemia (inflation to approximately 250 mmHg) followed by 10 minutes of reperfusion (deflation). The total duration of the conditioning procedure is 60 minutes. Participants subsequently undergo free flap reconstruction according to standard institutional protocols.

Device: Remote ischemic preconditiong

Interventions

The intervention consists of three cycles of ischemia and reperfusion applied to the upper arm using a pneumatic tourniquet. Each cycle includes 10 minutes of ischemia (inflation to approximately 250 mmHg) followed by 10 minutes of reperfusion (deflation). The total duration of the conditioning procedure is 60 minutes. Participants subsequently undergo free flap reconstruction according to standard institutional protocols.

Early RIPCLate RIPC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Patients undergoing free flap reconstruction surgery for reconstruction of body surface defects
  • Treatment at the Department of Plastic Surgery, BG Universitätsklinikum Bergmannsheil Bochum
  • Ability to understand the study procedures
  • Written informed consent to participate in the study

You may not qualify if:

  • Refusal or inability to provide informed consent
  • Contraindications to regional nerve block or perioperative procedures required for the study
  • Any condition that prevents participation according to investigator judgment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BG University Clinic Bergmannsheil

Bochum, North Rhine-Westphalia, 44789, Germany

Location

Related Publications (2)

  • Drysch M, Fiedler A, Schmidt SV, Reinkemeier F, Puscz F, Kurbacher T, Frey UH, Ochsenfarth C, Lehnhardt M, Wallner C, Sogorski A. Systemic downregulation of EV-associated MiRNAs following remote ischemic preconditioning. Sci Rep. 2025 Dec 11;15(1):43657. doi: 10.1038/s41598-025-31356-9.

  • Drysch M, Fiedler A, Kurbacher T, Schmidt SV, Reinkemeier F, Puscz F, Becerikli M, Fueth M, Weskamp P, Lehnhardt M, Wallner C, Sogorski A. Ischemia-Reperfusion Injury in Free Flaps: Molecular Mechanisms and Protective Effects of Remote Ischemic Preconditioning. J Cell Mol Med. 2025 Aug;29(15):e70739. doi: 10.1111/jcmm.70739.

MeSH Terms

Conditions

Reperfusion InjuryIschemia

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants undergoing free flap reconstruction will be randomly assigned to one of three parallel groups: (1) no remote ischemic conditioning (control), (2) remote ischemic conditioning 12-24 hours prior to surgery, or (3) remote ischemic conditioning immediately prior to surgery. Participants remain in their assigned study arm throughout the study period. In cases of postoperative flap perfusion compromise requiring revision surgery, participants will undergo a secondary randomization to receive either additional remote ischemic conditioning or no conditioning prior to revision.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician, Department of Plastic, Reconstructive and Burn Surgery

Study Record Dates

First Submitted

March 17, 2026

First Posted

March 23, 2026

Study Start

April 1, 2021

Primary Completion

December 31, 2022

Study Completion

December 31, 2023

Last Updated

March 25, 2026

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Individual participant data collected in this study will not be made publicly available. All study data will be pseudonymized and stored on secure institutional servers with access restricted to authorized study personnel. Data are collected as part of a single-center clinical study and contain potentially identifiable clinical information. Aggregated results may be published in scientific journals, but individual-level data will not be shared outside the study team in order to protect participant confidentiality.

Locations